Linda McCall
About
Linda McCall is a scholar working on Cancer Research, Oncology and Surgery.
According to data from OpenAlex, Linda McCall has authored 62 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 29 papers in Oncology and 21 papers in Surgery. Recurrent topics in Linda McCall's work include Breast Cancer Treatment Studies (40 papers), Breast Lesions and Carcinomas (19 papers) and Breast Implant and Reconstruction (15 papers). Linda McCall is often cited by papers focused on Breast Cancer Treatment Studies (40 papers), Breast Lesions and Carcinomas (19 papers) and Breast Implant and Reconstruction (15 papers). Linda McCall collaborates with scholars based in United States, India and Switzerland. Linda McCall's co-authors include Kelly K. Hunt, Karla V. Ballman, Armando E. Giuliano, A. Marilyn Leitch, Peter Blumencranz, Peter D. Beitsch, Pat W. Whitworth, Sukamal Saha, Monica Morrow and Judy C. Boughey and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.
In The Last Decade
Linda McCall
62 papers receiving 6.2k citations
Hit Papers
Peers
Linda McCall
Concetta De Cicco Italy
Sukamal Saha United States
Pat W. Whitworth United States
Seth P. Harlow United States
Kambiz Dowlatshahi United States
Peter D. Beitsch United States
Pauline T. Truong Canada
Henry Yeung United States
R Zucali Italy
G Contesso France
Citations per year, relative to Linda McCall Linda McCall (= 1×)
peers
Concetta De Cicco
Countries citing papers authored by Linda McCall
Since
Specialization
Citations
This map shows the geographic impact of Linda McCall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda McCall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda McCall more than expected).
Fields of papers citing papers by Linda McCall
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Linda McCall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda McCall. The network helps show where Linda McCall may publish in the future.
Co-authorship network of co-authors of Linda McCall
This figure shows the co-authorship network connecting the top 25 collaborators of Linda McCall. A scholar is included among the top collaborators of Linda McCall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda McCall. Linda McCall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Boughey, Judy C., Kari M. Rosenkranz, Karla V. Ballman, et al.. (2023). Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance). Cancer Research. 83(5_Supplement). GS4–1.
2.
O’Sullivan, Ciara C., Karla V. Ballman, Linda McCall, et al.. (2021). Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer. Future Oncology. 17(34). 4665–4676.
3.
Katz, Matthew S., Linda McCall, Karla V. Ballman, et al.. (2020). Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations. Breast Cancer Research and Treatment. 185(3). 891–891.
4.
Rosenkranz, Kari M., Karla V. Ballman, Linda McCall, et al.. (2020). Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study. Annals of Surgical Oncology. 27(12). 4650–4661.
5.
Boughey, Judy C., Karla V. Ballman, Linda McCall, et al.. (2017). Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. Annals of Surgery. 266(4). 667–676.
6.
Singendonk, Maartje, Taher Omari, Christine Feinle‐Bisset, et al.. (2017). Upper Gastrointestinal Function in Morbidly Obese Adolescents Before and 6 Months After Gastric Banding. Obesity Surgery. 28(5). 1277–1288.
7.
Giuliano, Armando E., Karla V. Ballman, Linda McCall, et al.. (2016). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 264(3). 413–420.
8.
Boughey, Judy C., Linda McCall, Karla V. Ballman, et al.. (2014). Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer. Annals of Surgery. 260(4). 608–616.
9.
Buzdar, Aman U., Vera J. Suman, Funda Meric‐Bernstam, et al.. (2013). Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial. The Lancet Oncology. 14(13). 1317–1325.
10.
Thrall, Donald Ε., Paolo F. Maccarini, Paul R. Stauffer, et al.. (2012). Thermal dose fractionation affects tumour physiological response. International Journal of Hyperthermia. 28(5). 431–440.
11.
McCarter, Martin D., Cristina R. Antonescu, Karla V. Ballman, et al.. (2012). Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence. Journal of the American College of Surgeons. 215(1). 53–59.
12.
Hunt, Kelly K., Karla V. Ballman, Linda McCall, et al.. (2012). Factors Associated With Local-Regional Recurrence After a Negative Sentinel Node Dissection. Annals of Surgery. 256(3). 428–436.
13.
Le‐Petross, Huong T., Linda McCall, Kelly K. Hunt, et al.. (2012). Role of axillary ultrasound after neoadjuvant chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis (ACOSOG Z1071).. Journal of Clinical Oncology. 30(15_suppl). 1107–1107.
14.
Chi, Jen‐Tsan, Donald Ε. Thrall, J Chen, et al.. (2011). Comparison of Genomics and Functional Imaging from Canine Sarcomas Treated with Thermoradiotherapy Predicts Therapeutic Response and Identifies Combination Therapeutics. Clinical Cancer Research. 17(8). 2549–2560.
15.
Civantos, Francisco, Robert P. Zitsch, David E. Schuller, et al.. (2010). Sentinel Lymph Node Biopsy Accurately Stages the Regional Lymph Nodes for T1-T2 Oral Squamous Cell Carcinomas: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology. 28(8). 1395–1400.
16.
Vujašković, Željko, Dong Wook Kim, Ellen L. Jones, et al.. (2010). A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. International Journal of Hyperthermia. 26(5). 514–521.
17.
Giuliano, Armando E., Linda McCall, Peter D. Beitsch, et al.. (2010). Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases. Annals of Surgery. 252(3). 426–433.
18.
Wilke, Lee G., Linda McCall, Katherine E. Posther, et al.. (2006). Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial. Annals of Surgical Oncology. 13(4). 491–500.
19.
Posther, Katherine E., Linda McCall, Peter Blumencranz, et al.. (2005). Sentinel Node Skills Verification and Surgeon Performance. Annals of Surgery. 242(4). 593–602.
20.
Leitch, A. Marilyn, Peter D. Beitsch, Linda McCall, et al.. (2005). Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. The American Journal of Surgery. 190(4). 539–542.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Concetta De Cicco Breakdown of academic impact, for papers by Sukamal Saha Breakdown of academic impact, for papers by Pat W. Whitworth Breakdown of academic impact, for papers by Seth P. Harlow Breakdown of academic impact, for papers by Kambiz Dowlatshahi Breakdown of academic impact, for papers by Peter D. Beitsch Breakdown of academic impact, for papers by Pauline T. Truong Breakdown of academic impact, for papers by Henry Yeung Breakdown of academic impact, for papers by R Zucali Breakdown of academic impact, for papers by G Contesso